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1. Introduction
  Bone marrow is a delicate microenvironment in which 
many cell types (such as hematopoietic cells and 
immunocytes) are generated, keeping a very important role 
in body homostatasis and body health. However, in some 
disease conditions, such as breast and prostate cancers, 
bone marrow also offers a suitable microenvironment for 
tumor metastasis and development[1]. At present, prostate 
cancer has been confirmed as one of the most common 
cancer and leading cause of cancer-related deaths in the 
world[2]. It is characterized by a very predictive progression 
from an early hormone-sensitive form that can be treated 
by androgen deprivation therapy to a hormone-refractory 
form that occurs within the axial skeleton[3]. Once prostate 
cancer becomes hormone refractory, it is essentially 
incurable and is more preferent to transfer into the state 
of the secondary bone metastases, in which their sequelae 
are lethal to patients[2-4]. Thus, it is very important to 
uncover the potential mechanisms behind the preferential 
metastasis and growth of certain cancers (such as breast 
and prostate cancer) in bone marrow microenvironment 
if want to cure these cancers in the future. It is generally 
accepted that cancer is not simply a disease involving a 
single tumor cell that grows out of control, but is a dynamic 
interaction between the tumor cells and its surrounding 
microenvironment[5]. Factors present within the bone 
microenvironment, whether insoluble components of the 
extracellular matrix or soluble factors (such as cytokines 
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and mitogens) secreted by host cells, and direct cell-to-
cell interactions are thought to contribute to the preferential 
metastasis and growth of prostate cancer cells in bone 
marrow[5-7].
  More and more evidence has demonstrated that bone 
stromal cells affect prostate cancer cells and can be changed 
by their interactions with the cancer cells[5,8]. Chung and 
collaborators indicated that growth of both benign and 
malignant prostate cancers in vivo is heavily dependent 
on the cells of the host environment, including the stromal 
cells[9, 10]. O’Connor and collaborators found that bone 
marrow tromal cells coculture with prostate cancer cells 
alters endoglin expression and attenuates transforming 
growth Factor-毬 signaling in reactive bone marrow stromal 
cells[11]. 
  Previous studies have demonstrated that endoglin is a 
homodimeric transmembrane glycoprotein that can bind 
specifically to transforming growth factor 毬1 (TGF-毬1) and 
TGF-毬3, as well as activin A and several bone morphogenic 
proteins, after incorporation with one of two transmembrane 
serine-threonine kinases known as TGF-毬 receptor I 
and TGF-毬 receptor II[12]. Endoglin is constitutively 
phosphorylated, but it is not an active signaling molecule 
and only works as a auxiliary regulatory component by 
formation of a heteromeric complex with the TGF-毬
receptor, by which it regulates the signaling of distinct TGF-
毬 receptor I isotypes known as activin receptor-like kinase 
(ALK)-1 and ALK-5[13,14]. After formation of the activated 
heteromeric complex, endoglin initiates an intracellular 
signaling cascade by which specific Smad proteins are 
activated and further signals are transduced into the 
nucleus where they regulate the transcription of series genes 
involved in maintaining normal physiologic functions such 
as cell proliferation, apoptosis, cell motility and adhesion[15].
  Antiaris toxicaria is widely growing over tropical areas 
in Southeast Asia. Early studies of the toxic agents of 
this plant in Indonesia and Malaysia have resulted in the 
isolation of several kinds of cardenolides from the latex, 
seeds, and stem[16,17]. Traditionally, cardenolides are 
generally accepted in treatment of congestive heart failure 
and as anti-arrhythmic agents[18-20], but recent studies 
have demonstrated that certain cardenolides extracted 
from some plants or animals are involved in complex cell 
signal transduction mechanisms that may have important 
consequences in blocking tumor cell proliferation and 
inducing tumor apoptosis[21-27]. In recent years, our research 
group has isolated three new cytotoxic cardenolides from 
the latex of Antiaris toxicaria, which were further proved to 
possess the capabilities of significant cytotoxicity against 
K562, SGC-7901, SMMC-7721 and HeLa cell lines[28, 29]. In 
the present study, we found that toxicarioside A, isolated 
from Antiaris toxicaria in Hainan China, had the capability 
of inhibiting endoglin expression and altering TGF-毬 
signaling in a bone marrow stromal cell line, which results 
in inhibition of cell proliferation. Our results uncover a 
possible mechanism of toxicarioside A in action against 
metastatic bone tumors. 
2. Materials and methods
2.1. Isolation and identification of toxicarioside A
  Latex of Antiaris toxicaria was collected in Lingshui 
county of Hainan Province, China, in November 2005. The 
plant was validated by Professor Zhu-nian Wang in the 
Institute of Crops Genetic Resources, Chinese Academy 
of Tropical Agricultural Sciences. The voucher specimen 
was numbered as AN200511 and deposited in the Institute of 
Tropical Bioscience and Biotechnology, Chinese Academy 
of Tropical Agricultural Sciences. Toxicarioside A was 
isolated from the fractionation of the 60% ethanol extract of 
the latex of Antiaris toxicaria as we previously reported[28] 
and its structure was elucidated by comprehensive 
analysis of 1D and 2D NMR spectra (data not shown). The 
resultant toxicarioside A was dissolved in DMSO in a stock 
concentration (1 mg/mL) for subsequent experiments.
2.2. Cell culture and toxicarioside A treatment
  Human bone marrow stromal cell lines HS-5 (CRL-11882) 
was purchased from the American Type Culture Collection 
(ATCC). The HS-5 cells were cultured in low-glucose DMEM 
medium (Gibical) and supplemented with 10% fetal bovine 
serum, 2 mmol/L glutamine, 100 IU/mL penicillin and 100 毺g/mL 
streptomycin at 37 曟 in a humidified atmosphere with 5% 
CO2. For analysis of endoglin expression and Smad signaling 
in HS-5 cells, recombinant TGF-毬1 or BMP-2 (eBioscience) 
100 ng/mL was added into the DMEM medium. The 
logarithmic phase or different time point cells were used for 
subsequent experiments. 
2.3. RNA isolation and Northern blot analysis
  Total RNA was isolated directly from HS-5 cells using 
TRIzol reagent (Gibco-BRL/Invitrogen) as recommended 
by the manufacturer’s instructions. For Northern blot 
analysis, RNA was transferred to Hybond N+ membranes and 
then hybridized with full-length cDNA probes for murine 
endoglin and 毬-actin in PerfectHyb Plus hybridization 
buffer (Sigma-Aldrich) according to the manufacturer’s 
instructions. Digital images were acquired and analyzed 
with a gel imaging system (Bio-Rad Gel Doc1000, Bio-
Rad). The resultant mRNA level were relatively compared to 
毬-actin and expressed as percent of 毬-actin.
2.4. Western blot analysis
  Western blot analysis was performed as described 
previously[30-32]. Total cellular protein was prepared 
by solubilizing the HS-5 cells with SEB. The protein 
concentration of each sample was determined by the Lowry 
methods. Fifteen micrograms of total cell protein were used 
to analysis for endoglin, TGF-毬, Smad1, Smad2, pAmad1 
and pSmad2. All membranes were probed with antibodies 
to 毬-actin to correct for loading and transfer differences 
among samples. Before loading, all cell lysates were added 
to an equal volume, heated at 100 曟 for 5 min. Thereafter, 
the proteins were separated by SDS-PAGE using Bio-Rad 
Criterion Tris-HCl gels with a 4% (w/v) polyacrylamide 
stacking gel and a 10% (w/v) polyacrylamide resolving gel 
in gel running buffer (150 mmol/L glycine, 50 mmol/L Tris 
base, 0.1% (v/v) SDS, pH 8.8) under constant voltage. The 
fractionated proteins were transferred to a polyvinylidene 
Fluoride (PVDF) membrane at 4 曟 for 5 h at 50 V in transfer 
buffer (100 mmol/L glycine, 100 mmol/L Tris base, pH 8.3). 
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The PVDF membranes were blocked overnight at 4 曟 with 
gentle rotary agitation in TBS/0.1% (v/v) Tween 20 (TBST). 
The primary antibodies for 毬-actin (1:15 000; Abcam), 
endoglin (1:250; Santa Cruz Biotechnology), Smad1 (1:1 000; 
Cell Signaling Technology, Inc.), Smad2 and pSmad1
(1:1 000; Cell Signaling Technology) were applied in 5% 
(v/v) bovine serum albumin. All primary antibodies were 
incubated overnight at 4 曟 with gentle rotary agitation. 
The blots were washed at least three times for 10 min each 
at room temperature with PBST. The secondary antibodies, 
horseradish peroxidase-conjugated sheep anti-mouse IgG, 
were added to blocking solution at 1:10 000 dilutions and 
incubated for 2 h at room temperature with gentle rotary 
agitation. After three 10 min washes with PBST at room 
temperature, detection was carried out using the enhanced 
chemiluminescence system (Amersham) as previously 
reported[33]. Digital images were acquired and analyzed with 
a gel imaging system (Bio-Rad Gel Doc1000, Bio-Rad). The 
resultant protein level was relatively compared to 毬-actin 
and expressed as percent of 毬-actin.
2.5. Cell proliferation assay
  For evaluation of cell proliferation, HS-5 cells were plated 
into 96-well plates at a concentration of 5 000 per well and 
cultured as the condition as indicated above. Exposures 
were done on six wells for each conditioned medium feeder 
cell line. On test day 3, growing cultures of HS-5 cells were 
labeled with 100 毺mol/L 5-bromo-2-deoxyuridine for 4 h
at 37 曟 in a humidified air/CO2 (95:5, v/v) atmosphere. After 
labeling, cell proliferation was measured using a Roche 
Cell Proliferation ELISA kit (Roche Diagnostics). In brief, 
the medium from each well was aspirated, HS-5 cells were 
fixed for 30 min with 200 毺L fixative buffers, and the fixed 
cells were incubated with an immunoreagent containing 
antibodies specific for 5-bromo-2-deoxyuridine for 90 min 
at room temperature. The ELISA plates were washed and 
incubated for about 15 min with a colorimetric substrate, 
the reaction was stopped by the addition of 1 mol/L
sulfuric acid, and cell proliferation was determined by 
measuring the absorbance at 450 nm. Total cell protein per 
well was quantitated on at least three wells that were plated 
concurrently to normalize cell proliferation for cell number. 
Wells designated for protein quantification were lysed with 
25 毺L of RIPA buffer and quantified using the Pierce BCA 
Protein Assay as reported previously[11].
2.6. Preparation of small interference RNA against endoglin 
and cell infection
  Small interference RNA (siRNA) against endoglin was 
prepared as previously reported[11,34]. Briefly, siRNA 
duplexes against murine endoglin were designed and 
synthesized by a commercial biotechnological company 
(Takara, China). Scrambled siRNA was also obtained from 
Takara and was used as the control siRNA. HS-5 cells were 
transfected with the siRNA duplexes by electroporation 
using a electroporation system (Bio-Rad Gene Pulser II). 
For transfection, 2 伊 106 cells were resuspended in 1 mL 
electroporation buffer with 200 nmol/L dsRNA. Thereafter, 
the resuspended cells were transferred to a Gene Pulser cuvette 
(Bio-Rad) and electroporated (1 pulse, 0.2 kV, 0.3 毺F,
73.8 ms). The electroporated cells were then combined, 
mixed with 4 mL cultured medium, and plated onto four 
wells of a six-well culture plate at a concentration of 1
伊106 per well. All cultures were incubated at 37 曟 in a 
humidified air/CO2 (95:5, v/v) atmosphere for the duration of 
the experiment. At 24 h post-transfection, the toxicarioside 
A and DMSO were added into the cultured medium for the 
next 24 to 48 h. The cultured cells were collected and used 
for Western blot analysis as above.
2.7. Statistical analysis
  All data are expressed as mean依SEM. For analysis of 
differences between two groups, a Student’s t test was 
performed. For multiple groups, an ANOVA was carried out 
followed by a Student-Newman-Keuls test. The level of 
statistical significance was set at P < 0.05.
3. Results
3.1. Inhibition of endoglin expression by toxicarioside A
  Endoglin mRNA expression was analyzed by Northern 
blot. HS-5 cells were cultured in different concentration 
of toxicarioside A (0.5 to 9.0 毺g/mL) and total mRNA was 
isolated to perform Northern blot analysis. The results of 
Northern blot analysis showed that toxicarioside A treatment 
inhibited endoglin mRNA expression in a dose-dependent 
pattern. toxicarioside A 0.5 to 9.0 毺g/mL induced 
significant inhibition of endoglin expression when compared 
with not treated (0 毺g/mL) cells and different does (Figure 1A,
P<0.001). In addition, endoglin protein was isolated by SDS/
PAGE and detected by Western blot analysis. Similar results 
were found as in the Northern blot analysis (Figure 1B). 
Endoglin protein expression was also shown in a pattern of 
dose-dependent in HS-5 cells (Figure 1B). These results 
indicated that toxicarioside A has powerful capabilities of 
inhibiting endoglin expression in HS-5 cells. Meanwhile, 
these results also indicated that the optimum effective dose 
of toxicarioside A was between 1.5 to 4.5 毺g/mL. Therefore, 
the concentration of toxicarioside A for subsequent 
experiments related to treatment of HS-5 cell treatment was 
2.5 毺g/mL. 
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Figure 1. Inhibition of endoglin expression by toxicarioside A. 
HS-5 cells were cultured in various dose of toxicarioside A (0-9 毺g/mL)
for 48 h. Endoglin mRNA and protein were detected by Northern blot 
(A) and Western blot (B) analysis. *P < 0.001 or less, compared to the 
various dose of toxicarioside A. 
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3.2. Inhibition of TGF-毬 expression by toxicarioside A
  To understand whether toxicarioside A could attenuate 
TGF-毬 expression in HS-5 cells, we still used Western blot 
analysis to detect the TGF-毬 protein in the HS-5 cells. HS-5 
cells were cultured in DMEM medium contained toxicarioside 
A 2.5 毺g/mL or DMSO for 24 h. Thereafter, HS-5 cells were 
isolated by SDS-PAGE and blotted by a monoclonal antibody 
against TGF-毬. The Western blot results showed that the 
TGF-毬 expression was significantly attenuated in the HS-5 
cells treated with toxicarioside A when in comparison with 
the HS-5 cells treated with DMSO, 11.5依1.6 (percent of 毬
-actin) in toxicarioside A-treated cells versus 77.3依8.8 in 
DMSO-treated cells, more than 6 folds decrease (Figure 2, P 
< 0.001).
TGF-毬
毬-Actin
Figure 2. Inhibition of TGF-毬 expression by toxicarioside A.
HS-5 cells were cultured in DMEM medium supplemented with 
toxicarioside A 3 毺g/mL for 48 h. TGF-毬 protein was detected by 
Western blot analysis. *P<0.001 or less, compared to the DMSO-
treated HS-5 cells.
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Figure 3. Suppression of cell proliferation by toxicarioside A. 
HS-5 cells were cultured in various dose of toxicarioside A (0-9 毺g/mL)
for 24 or 48 h Cell proliferation was detected by Proliferation ELISA 
kit (Roche Diagnostics). *P < 0.001 or less, compared to the various 
dose or DMSO-treated HS-5 cells.
3.3. Suppression of cell proliferation by toxicarioside A
  To know whether decreased expression of endoglin and 
TGF-毬 influence cell functions in HS-5 cells, we thus we 
detected the cell proliferation induced by toxicarioside 
A. Cell proliferation was performed by commercial 
Proliferation ELISA kit. Compared with the HS-5 cells 
treated with DMSO, the cell proliferation in the HS-5 cells 
treated with toxicarioside A showed significantly decreased 
also in a dose-dependent pattern (Figure 3, P < 0.001) 
when compared with not treated (0 毺g/mL) cells, DMSO-
treated cells and different does (0.5 to 9 毺g/mL), which was 
consistent with the decreased levels of endoglin and TGF-
毬 in the toxicarioside A-treated HS-5 cells, suggesting 
endoglin and TGF-毬 signaling is related to the HS-5 cell 
proliferation.
3.4. Alteration of Smad signaling by toxicarioside A
  Previous studies have concluded that endoglin acts as a 
positive regulator of ALK1 signaling and a negative regulator 
of ALK5 signaling in endothelial cells. Therefore, we 
detected Smad1, Smad 2 and their active phosphorylated 
counterparts, pSmad1 and pSmad2. In HS-5 cells, both 
Smad1 and Smad2 could be attenuated by toxicarioside 
A when compared with the HS-5 cells treated with DMSO 
(Figure 4, P < 0.000 1). In addition, similar results were 
found to the active phosphorylated Smad1 and Smad2, 
pSmad1 and pSmad2. Western blot analysis indicated that 
pSmad1 and pSmad2 were also attenuated in HS-5 cells 
treated by toxicarioside A, but keep unaffected in the HS-5 
cells treated with DMSO, Smad1, pSmad1,  Smad2 and 
pSmad2 were 12.3依1.6, 15.1依2.1, 9.1依1.3 and 10.5依1.5 in the 
HS-5 cells treated with toxicarioside A versus 71.7依6.9, 61.2
依2.1, 70.3依7.3 and 58.9依4.6 in the HS-5 cells treated with 
DMSO (Figure 4). Significant differences were found between 
toxicarioside A-treated and DMSO-treated HS-5 cells (P < 
0.001). These results also indicate that inhibition of endoglin 
and TGF-毬 expression in HS-5 cells lead to attenuation of 
both ALK1 and ALK5 signaling pathways, which resulted in 
suppression of HS-5 cells proliferation.
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Figure 4. Alteration of Smad signaling by toxicarioside A.
HS-5 cells were treated with toxicarioside A (3 毺g/mL) or DMSO, 
Smad1, Smad2 and active phosphorylated Smad1 (pSmad1), 
phosphorylated Smad2 (pSmad2) were detected by Western blot 
analysis. *P<0.001 or less, compared to the DMSO-treated HS-5 
cells.
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Figure 5. Alteration of Smad signaling by endoglin interference.
HS-5 cells were interfered or not interfered with siRNA against 
endoglin. Endoglin, Smad1 and Smad2 were then detected by Western 
blot analysis. *P<0.001 or less, compared to the not siRNA HS-5 
cells.
3.5. Alteration of Smad signaling by endoglin interference
  Due to the role of endoglin in TGF-毬 signaling and 
decreased expression of endoglin and TGF-毬 in HS-5 cells 
treated with toxicarioside A, we next used RNA interference 
to uncover the roles played by endoglin or TGF-毬 in the 
effects on Smad signaling in HS-5 cells. We thus used a 
siRNA against endoglin to attenuate endoglin protein level 
in HS-5 cells. Our results showed that endoglin protein 
level was decreased by about 7 folds (7.6依1.0 in siRNA HS-5 
cells and 52.4依4.6 in not siRNA HS-5 cells, respectively) 
after transfection with siRNA against endoglin in HS-5 cells 
(Figure 5, P<0.001), suggesting the siRNA against endoglin 
effectively blocked the endolgin expression in HS-5 cells.
  To know whether attenuation of endoglin expression is 
the major reason that caused Smad1 and Smad2 signaliing 
atteration in HS-5 cells, we next detected the TGF-毬, 
Smad1 and Smad2 proteins in HS-5 cells. After blocking 
the expression of endoglin by siRNA, we found TGF-毬 
expression was not affected by the endoglin interference, 
36.4依4.2 versus 38.9依3.2 (Figure 5, P>0.05). However, 
Smad1 and Smad2 proteins were significantly decreased 
in endoglin siRNA HS-5 cells when comparison with the 
not siRNA HS-5 cells, 8.6依0.9 (% to 毬-actin) and 4.9依
0.7 versus 35.2依3.7 and 27.6依2.8, respectively (Figure 5, 
P < 0.001). These results indicated that the alteration of the 
Smad1 and Smad2 singling in HS-5 cells by toxicarioside 
A treatment was direct results of decreased endolgin 
expression and not related to other cellular changes, such as 
self-secreted TGF-毬.
4. Discussion
  In general, endoglin is considered as angiogenesis-related 
molecule as vascular endothelial growth factor by many 
previous studies. Endoglin works as a auxiliary regulatory 
component by formation of a heteromeric complex with 
the TGF-毬 receptor, by which it regulates the signaling of 
distinct TGF-毬 receptor I isotypes ALK-1 and ALK-5[13,14]. 
In addition, many study results also indicate that endoglin 
mainly expresses in active endothelial cells, in which it 
help new vessel formation in such conditions as tumor 
and inflammation[35,36]. However, in our present study, we 
found that both endoglin and its one of ligands, TGF-毬,
were expressed in a normal bone marrow stromal cell line, 
HS-5, and their expressions was attenuated by  toxicarioside 
A, a cardenolide isolated from the latex of a tropical 
Antiaris toxicaria, in Hainan Island, China. Moreover, in the 
present study, we still found that toxicarioside A treatment 
also caused inhibition of cell proliferation in HS-5 cells. 
Therefore, we next used Western blot analysis to detect the 
ALK1 and ALK5’s downstream molecules, Smad1, Smad2 
and their active phosphorylated counterparts, pSmad1 and 
pSmad2. Our results showed that Smad1, Smad2, pSmad1 
and pSmad2 were all attenuated in HS-5 cells treated with 
toxicarioside A, but not in the control HS-5 cells treated 
with DMSO. Because we found both endoglin and TGF-毬 in 
the HS-5 cells treated with toxicarioside A were attenuated, 
we further used RNA interference (siRNA) to knockdown the 
endoglin expression in HS-5 cells in order to identify which 
the major molecules that took the special role in controlling 
ALK1 and ALK5 signal pathways between endoglin and 
TGF-毬. Our results indicated that both ALK1 and ALK5’s 
downstream molecules, Smad1 and Smad2 were significantly 
decreased in the siRNA HS-5 cells, but keep unaffected in 
the not siRNA HS-5 cells. Taking all the results together 
in the present study, we can conclude that it is endoglin 
but not TGF-毬 that causes the normal ALK1 and ALK5 
signal pathways and keep HS-5 cell in normal function, 
and that toxicarioside A treatment can induce inhibiton of 
endoglin and TGF-毬 expression in HS-5 cells, which lead to 
decreased HS-5 cell proliferation at last.
  Stromal cell is one of the important cell types in bone 
marrow microenviroment. Recently, O’Connor and their 
coworkers used tumor cultured media to culture bone-
marrow stromal cells and found that some unknown 
substances in some prostate cancer cells can inhibit 
endoglin expression in some stromal cell lines, the 
inhibition of endolgin expression also decrease stromal 
cell proliferation and potentially facilitate prostate cancer 
metastasis in the bone marrow[11]. As we know, endoglin 
has been considered as one of the hallmark molecules that 
lead to new vessel formation, and monoclonal antibodies 
and other strategies to block the funtion of endoglin reach 
convincible antitumor activities[37,38]. In our present 
study, we found that toxicarioside A can inhibit endoglin 
expression and cell proliferation in HS-5 cells, which 
indicate toxicarioside A is not suitable for treatment of 
prostate cancer if use toxicarioside A as cytotoxic agent. 
Reversely, we still found that toxicarioside A can inhibit 
endoglin expression in some tumor cells and induce 
effective antitumor activities in vivo through suppression of 
endoglin-related tumor angiogenesis, which let the tumor 
lack of blood support and nutrition and cell apotosis at last 
(unpublished data). From this conflict results, we think 
that toxicarioside A posses antitumor activities but is not 
suitable for all the tumor type, such as breast and prostate 
cancers that are preferential metastasis and growth in bone 
marrow microenvironment.
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  Antiaris toxicaria is growth widespread in tropical areas, 
such as southeastern Asia. At present, there are many fairy 
tales about the plant in the ancient times, especially its 
poison for arrows, darts and blow-darts. Modern biomedical 
studies have isolated many chemical effective ingredients 
from its latex sap[39], in which the most focus is on the active 
complex mixture of cardenolide glycosides[28,39-42]. Besides 
the traditional effect of the cardenolides on the inhibition 
of the ubiquitous cell surface Na+, K+-ATPase, there 
has been a substantial increase in the number of studies 
investigating the effects of cardiac glycosides on the growth 
of human malignant tumor cells and its possible molecular 
mechanisms in the last decade[23-27]. In our previous works, 
we have isolated three new cytotoxic cardenolides from the 
latex of Antiaris toxicaria and have proved them possess 
the capabilities of significant cytotoxicity against several 
human tumor cell lines in vitro[28, 29]. In the present study, 
we further investigated its other potential medicinal value 
in HS-5 cells. Our results indicate that toxicarioside A 
really has other function except for cardiac and antitumor 
activities. Although its inhibiting function against endoglin 
expression in HS-5 cells in this study is a potential reason 
that promote cancer metastasis and growth in bone marrow 
microenvironment, it really suggests that toxicarioside A 
must be reconsidered if use it as a cytotoxic antiumor agent 
for tumor therapy in the future.
  In the present study, we found both endoglin and TGF-毬
were attenuated in the HS-5 cells treated with toxicarioside 
A. In order to determine if the effects were the result of 
a primary affect on endoglin or TGF-毬 attenuation or 
the result of other substance changes in the HS-5 cells, 
endoglin expression was selectively blocked in HS-5 cells 
using siRNA. Similar to what was observed in the HS-5 cells 
treated with toxicarioside A, endoglin protein levels were 
decreased and both Smad1 and Smad2 signaling pathways 
were altered in the HS-5 cells transfected with endoglin 
siRNA. Smad1 but Smad2 protein levels were significantly 
decreased, suggesting the attenuation of the Smad1-related 
ALK1 and Smad2-related ALK5 signaling pathways is 
induced by endoglin but not by other factors (such as TGF-
毬). 
  Many previous studies in endothelial cells have certified 
that endoglin is a positive regulator of ALK1 signaling and a 
negative regulator of ALK5 signaling[43,44]. However, in the 
present study, our results demonstrated that toxicarioside A 
have the capabilities of inhibiting endoglin expression and 
attenuating Smad1-related ALK1 and Smad2-related ALK5 
signaling in HS-5 bone marrow stromal cells. In addition, 
the results of endoglin siRNA showed that blocked endoglin 
by siRNA itself caused significant attenuation of Smad1 and 
Smad2. These results suggest that endoglin is a positive 
regulator of both ALK1-induced Smad1/5/8 activation and 
ALK5-induced Smad2/3 activation. This is in contrast to the 
role that endoglin plays in endothelial cells.
  In summary, the results we found in this study indicate 
that toxicarioside A can inhibit endoglin expression in HS-5 
bone marrow stromal cells. The decreased expression of 
endoglin induces attenuation of both of both ALK1-induced 
Smad1/5/8 activation and ALK5-induced Smad2/3 activation, 
which results in inhibition of HS-5 cell proliferation. Our 
data disclose a possible mechanism of toxicarioside A in 
action against bone marrow microenvironment. 
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